Who are Ocular Therapeutix, Inc.'s main suppliers?

Ocular Therapeutix, Inc. (OCUL) key suppliers include: CELG-RI, CELG-RI, EyePoint, Inc., Opus Genetics, Inc., Kalaris Therapeutics, Inc.. View the full supplier network at chainsifter.com/chain/OCUL.

Who are Ocular Therapeutix, Inc.'s major customers?

Ocular Therapeutix, Inc. (OCUL) key customers include: CUSTOMER-1, CUSTOMER-2, CUSTOMER-3, CELG-RI, CELG-RI and 6 more. View the full customer network at chainsifter.com/chain/OCUL.

What sector is Ocular Therapeutix, Inc. in?

Ocular Therapeutix, Inc. (OCUL) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Ocular Therapeutix, Inc. Suppliers, Customers & Supply Chain (OCUL)

5Suppliers

11Customers

2Debt Items

20Related Chains

Source-Backed Evidence Depth

Ocular Therapeutix, Inc. (OCUL) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

19Total relationships

3Distinct source URLs

6High confidence

0.761Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Ocular Therapeutix, Inc. Suppliers

Ticker	Name	Confidence	Evidence
CELG-RI	CELG-RI	72%	uman use. European Union member states may approve a specific price for a drug product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the …
CELG-RI	CELG-RI	72%	Reciprocal relationship from CELG-RI graph: Reciprocal relationship from OCUL graph: uman use. European Union member states may approve a specific price for a drug product or it may instead adopt a s…
EYPT	EyePoint, Inc.	72%	Reciprocal relationship from EYPT graph: Reciprocal relationship from OCUL graph: Reciprocal relationship from EYPT graph: Reciprocal relationship from OCUL graph: Reciprocal relationship from EYPT g…
IRD	Opus Genetics, Inc.	72%	Reciprocal relationship from IRD graph: Reciprocal relationship from OCUL graph: Reciprocal relationship from IRD graph: line products, our business will be materially harmed. • Others may discover, …
KLRS	Kalaris Therapeutics, Inc.	72%	Reciprocal relationship from KLRS graph: or through collaborations or other arrangements with third parties. We intend to commercialize TH103, if approved, with our own specialty salesforce. There ar…

Ocular Therapeutix, Inc. Customers

Ticker	Name	Confidence	Evidence
CUSTOMER-1	CUSTOMER-1	90%	Three specialty distributor customers accounted for the following percentages of the Company’s total revenue: Customer 1 38 % 39 %
CUSTOMER-2	CUSTOMER-2	90%	Three specialty distributor customers accounted for the following percentages of the Company’s total revenue: Customer 2 28 24
CUSTOMER-3	CUSTOMER-3	90%	Three specialty distributor customers accounted for the following percentages of the Company’s total revenue: Customer 3 7 8
CELG-RI	CELG-RI	72%	uman use. European Union member states may approve a specific price for a drug product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the …
CELG-RI	CELG-RI	72%	Reciprocal relationship from CELG-RI graph: Reciprocal relationship from OCUL graph: Reciprocal relationship from CELG-RI graph: Reciprocal relationship from OCUL graph: Reciprocal relationship from …
EYPT	EyePoint, Inc.	72%	Reciprocal relationship from EYPT graph: Reciprocal relationship from OCUL graph: Reciprocal relationship from EYPT graph: Reciprocal relationship from OCUL graph: Reciprocal relationship from EYPT g…
IRD	Opus Genetics, Inc.	72%	Reciprocal relationship from IRD graph: line products, our business will be materially harmed. • Others may discover, develop, or commercialize products similar to those in our pipeline before or mor…
KLRS	Kalaris Therapeutics, Inc.	72%	Reciprocal relationship from KLRS graph: Reciprocal relationship from OCUL graph: Reciprocal relationship from KLRS graph: Reciprocal relationship from OCUL graph: Reciprocal relationship from KLRS g…
AFFAMED-THERAPEUTICS-LIMITED	AFFAMED-THERAPEUTICS-LIMITED	62%	. The new standard requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses a…
BARINGS-FINANCE-LLC	BARINGS-FINANCE-LLC	62%	. The new standard requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses a…
INCEPT-LLC	INCEPT-LLC	62%	e, laboratory and manufacturing space in Bedford, Massachusetts, which expire in July 2027, July 2028, and March 2031, and leases of equipment that expire between 2026 and 2028. In January 2026, we e…

Ocular Therapeutix, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
OCUL-DEBT-11486	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2024-12-31.
OCUL-DEBT	Debt stack $18.0M	90%	Market cache reports total debt of $18.0M.

Ocular Therapeutix, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Ocular Therapeutix, Inc..

Ocular Therapeutix, Inc. Ownership

Holder	Name	Confidence	Evidence
OCUL-OWNER-FMR-LLC	FMR LLC	90%	13F overlay lists FMR LLC as top holder; 272 tracked holders.

Ocular Therapeutix, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
LLY	Eli Lilly and Company	100.00	2
NVSEF	Novartis AG	100.00	2
ANIP	ANI Pharmaceuticals, Inc.	100.00	2
IRD	Opus Genetics, Inc.	100.00	1	['customer', 'supplier']
KLRS	Kalaris Therapeutics, Inc.	100.00	1	['customer', 'supplier']
EYPT	EyePoint, Inc.	100.00	1	['customer', 'supplier']
FDMT	4D Molecular Therapeutics, Inc.	100.00	2
OTLK	Outlook Therapeutics, Inc.	100.00	2
CELG-RI	BRISTOL MYERS SQUIBB CO	100.00	1	['customer', 'supplier']
REGN	Regeneron Pharmaceuticals, Inc.	100.00	2
TRVI	Trevi Therapeutics, Inc.	50.00	2
RNTX	Rein Therapeutics Inc.	50.00	2
PFE	Pfizer Inc.	50.00	2
PLAB	Photronics, Inc.	50.00	2
PLRX	Pliant Therapeutics, Inc.	50.00	2
PPBT	Purple Biotech Ltd	50.00	2
VYGR	Voyager Therapeutics, Inc.	50.00	2
ZBIO	Zenas BioPharma, Inc.	50.00	2
XLO	Xilio Therapeutics, Inc.	50.00	2
CELUW	Celularity Inc	50.00	2

Ocular Therapeutix, Inc. Supply Chain